Skip to main content

Cup-Tumore (Cancer of unknown primary)

  • Chapter
PET/CT-Atlas
  • 814 Accesses

Auszug

“Cancer of unknown primary” (CUP) (oder “metastases of unknown origin”, MUO) charakterisiert eine Tumorerkrankung, bei der der Primärtumor (zunächst) nicht bekannt ist und auch bei umfangreichster Diagnostik erst in der Autopsie erkannt wird [2, 8, 16].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Adams S, Baum RP, Stuckensen T, Bitter K, Hör G (1998) Prospective comparison of FDG PET with conventional imaging modalities CT, MRI, US in lymph node staging of head and neck cancer. Eur J Nucl Med 25:1255–1260

    Article  PubMed  CAS  Google Scholar 

  2. Assar OS, Fischbein NJ, Caputo GR et al. (1999) Metastatic head and neck cancer: Role and usefulness of FDG PET in locating occult primary tumors. Radiology 210:177–181

    Google Scholar 

  3. Bristow RE, del Carmen MG, Pannu HK et al. (2003) Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT. Gynecol Oncol 90:519–28

    Article  PubMed  Google Scholar 

  4. Burell StC, Van den Abbeele AD (2005) 2-deoxy-2-(F-18)fluoro-D-glucose-Positron emission tomography of the head and neck: An Atlas of the normal uptake and variants. Mol Imaging Biol 7:244–256

    Article  Google Scholar 

  5. Czernin J, Auerbach (2005) Clinical PET/CT imaging: Promises and misconceptions. Nuklearmedizin Suppl 1 44: S18–23

    PubMed  Google Scholar 

  6. Delgado-Bolton RC, Fernando-Perez C, Gonzalez-Meta A, Carreras JL (2003) Metaanalysis of the performance of 18FFDG PET in primary tumor detection in unknown primary tumors. J Nucl Med 44:1301–1314

    PubMed  Google Scholar 

  7. Gambhir SS, Czernin J, Schwimmer J et al. (2001) A Tabulated Summary of the FDG PET Literature. J Nucl Med (Suppl) 42:1–93

    Google Scholar 

  8. Greco FA, Hainsworth JD (1993) Cancer of unknown primary site. In: Devita VT Jr, Hellma NS, Rosenberg SA (Hrsg) Cancer: principles and practice of oncology. Lippincott-Raven, Philadelphia, pp 2072–2092

    Google Scholar 

  9. Gutzeit A, Antoch G, Kühl H et al. (2005) Unknown primary tumors: Detection with dual modality PET/CT-Initial experience. Radiology 234:227–234

    Article  PubMed  Google Scholar 

  10. Haskell CM (2001) Cancer treatment. WB Saunders, Philadelphia

    Google Scholar 

  11. Hör G (2001) Impact of Clinical (Satellite-) PET in Oncolog. Siemens, Erlangen A91100-M2300-A269-1-7600:2–16

    Google Scholar 

  12. Hör G, Mantaka P (1998) Application of PET in clinical oncology. In: Limouris GS, Shukla SK, Bender HF, Biersack HJ (Hrsg) Radionuclides for oncology — current status and future aspects. Mediterra, Athens, pp 107–111

    Google Scholar 

  13. Israel O, Mor M, Guralnik L et al. (2004) Is 18 F-FDG PET/ CT useful for imaging and management of patients with suspected and occult recurrence of cancer? J Nucl Med 45:2045–2051

    PubMed  Google Scholar 

  14. Johansen E, Eiftved A, Buchwald C et al. (2002) Implication of 18F-fluordeoxy-D-2 glucose positron emission tomography on management of carcionoma of unknown primary in the head and neck: A Danish cohort study. Laryngoscope 112:2009–14

    Article  PubMed  Google Scholar 

  15. Makaiova I, Vesely J, Kovacova S et al. (2002) False positive uptake of 18 FDG-fluorodeoxyglucose in the axillary brown fat lipoma (hibernoma)-case report. EANM, Abstr.

    Google Scholar 

  16. Manolidis S, Donald PJ, Volk P, Pounds TR (1998) The use of positron emission tomography scanning in occult and recurrent head and neck cancer. Acta Otolaryngol (Suppl) 534:1–11

    Article  CAS  Google Scholar 

  17. Mantaka P, Hertel A, Adams S et al. (1998) Contribution of PET-FDG in the diagnosis of cancer of unknown primary. In: Limouris GS, Shukla SK, Bender HF, Biersack HJ (Hrsg) Radionuclides for oncology — current status and future aspects. Mediterra, Athens, pp 121–131

    Google Scholar 

  18. Regelink G, Brouwer J, de Bree R et al. (2002) Detection of unknown primary tumours and distant metastases in patients with cervical metastases:value of FDG-PET versus conventional modalities. Eur J Nucl Med 29:1024–1030

    Article  CAS  Google Scholar 

  19. Scott CL, Cudaba I, Stewart JM et al. (2005) The utility of 2-deoxy-2-(F-18) fluoro-D-glucose positron emission tomography in the investigation of patients with disseminated carcinoma of unknown primary origin. Mol Imaging Biol 7:236–243

    Article  PubMed  Google Scholar 

  20. Sengupta MS, Lee SJ, Hoh CK et al. (1995) Utility and cost effectiveness of FDG whole body PET in patients with unknown primary malignancies (Abstr. 226). J Nucl Med 36:56

    Google Scholar 

  21. Wahl RL (2004) Why nearly all PET of abdominal and pelvic cancers will be performed as PET/CT. J Nucl Med Suppl 1 45:S81–95

    Google Scholar 

  22. von Schulthess GK (2003) Clinical Molecular Anatomic Imaging PET, PET/CT and SPECT/CT. Lippincott, London

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

(2006). Cup-Tumore (Cancer of unknown primary). In: PET/CT-Atlas. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-31215-3_12

Download citation

  • DOI: https://doi.org/10.1007/3-540-31215-3_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-31214-7

  • Online ISBN: 978-3-540-31215-4

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics